Table 2.
Bivariate correlations between SF-36, DHI, HADS and clinical characteristics of dizziness
| PCS-36 | MCS-36 | DHI | HADS | |
|---|---|---|---|---|
| PCS-36 |
1 |
|
|
|
| MCS-36 |
0.22** |
1 |
|
|
| DHI |
−0.64*** |
−0.57*** |
1 |
|
| HADS |
−0.32*** |
−0.82*** |
0.58*** |
1 |
| DoD |
0.13 |
−0.09 |
−0.01 |
0.004 |
| FoD |
−0.20* |
−0.03 |
0.24** |
0.04 |
| AvP |
0.24** |
0.10 |
−0.25** |
−0.07 |
| VNVa |
F = 7.94*** |
4.64* |
5.65** |
5.18** |
| Age |
−0.03 |
0.01 |
0.004 |
−0.02 |
| Gender | 0.03 | 0.13 | −0.12 | −0.03 |
Pearson correlations *p < 0.05, **p < 0.01, ***p < 0.001; Bonferroni corrected threshold for significance: p = 0.0017 - correlations surviving Bonferroni correction are bold; aAnvoa for VNV (vertigo, non-vertigo, mixed); SF-36: Medical Outcomes Studies 36-Item Short-Form Health Survey; MCS-36: SF-36 mental health component summary score, PCS-36: SF-36 physical component summary score; DHI: Dizziness Handicap Inventory sum score; HADS: Hospital Anxiety and Depression Scale; DoD: Duration of Dizziness; FoD: Frequency of Dizziness; AvP: attack versus permanent dizziness; VNV: variable for vertigo, non-vertigo and mixed dizziness.